RAYMOND DWEK

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

UNITED THERAPEUTICS Corp

Filing Date Source Excerpt
2021-08-19 Raymond Dwek Includes currently exercisable options to purchase 15,000 shares.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22